Displaying all 5 publications

Abstract:
Sort:
  1. Raghav K, Van Wijk AJ, Abdullah F, Islam MN, Bernatchez M, De Jongh A
    BMC Oral Health, 2016 Feb 27;16:25.
    PMID: 26920573 DOI: 10.1186/s12903-016-0186-z
    BACKGROUND: Virtual Reality Exposure Therapy (VRET) is found to be a promising and a viable alternative for in vivo exposure in the treatment of specific phobias. However, its usefulness for treating dental phobia is unexplored. The aims of the present study are to determine: (a) the efficacy of VRET versus informational pamphlet (IP) control group in terms of dental trait and state anxiety reductions at 1 week, 3 months and 6 months follow-up (b) the real-time physiological arousal [heart rate (HR)] of VRET group participants during and following therapy (c) the relation between subjective (presence) and objective (HR) measures during VRET.

    METHODS: This study is a single blind, randomized controlled trial with two parallel arms in which participants will be allocated to VRET or IP with a ratio of 1:1. Thirty participants (18-50 years) meeting the Phobia Checklist criteria of dental phobia will undergo block randomization with allocation concealment. The primary outcome measures include participants' dental trait anxiety (Modified Dental Anxiety Scale and Dental Fear Survey) and state anxiety (Visual Analogue Scale) measured at baseline (T0), at intervention (T1), 1-week (T2), 3 months (T3) and 6 months (T4) follow-up. A behavior test will be conducted before and after the intervention. The secondary outcome measures are real-time evaluation of HR and VR (Virtual Reality) experience (presence, realism, nausea) during and following the VRET intervention respectively. The data will be analyzed using intention-to-treat and per-protocol analysis.

    DISCUSSION: This study uses novel non-invasive VRET, which may provide a possible alternative treatment for dental anxiety and phobia.

    TRIAL REGISTRATION NUMBER: ISRCTN25824611 , Date of registration: 26 October 2015.

    Matched MeSH terms: Virtual Reality Exposure Therapy*
  2. Gujjar KR, van Wijk A, Kumar R, de Jongh A
    J Anxiety Disord, 2019 03;62:100-108.
    PMID: 30717830 DOI: 10.1016/j.janxdis.2018.12.001
    BACKGROUND: Although Virtual Reality Exposure Therapy (VRET) has proven to be effective in the treatment of various subtypes of specific phobia, there is limited evidence of its role in the treatment of dental phobia.

    METHOD: A single-blind RCT was conducted among 30 randomized patients with dental phobia to either VRET or informational pamphlet (IP) condition. Primary outcome anxiety measures (VAS-A, MDAS and DFS) were evaluated at baseline, pre- and post-intervention, 1-week, 3-months and 6-months follow-up. Secondary outcome measures assessed were pre-post behavioral avoidance, temporal variations of heart rate and VR-experience during and post-VRET, and dental treatment acceptance in both conditions at 6-month follow-up.

    RESULTS: Intention to treat analysis, using a repeated measures MANOVA, revealed a multivariate interaction effect between time and condition (p = 0.015) for all primary outcome measures (all ps 

    Matched MeSH terms: Virtual Reality Exposure Therapy/methods*
  3. Singh DK, Mohd Nordin NA, Abd Aziz NA, Lim BK, Soh LC
    BMC Neurol, 2013 Dec 13;13:199.
    PMID: 24330250 DOI: 10.1186/1471-2377-13-199
    BACKGROUND: Evidence indicates that the continuation of therapy among community-dwelling stroke survivors improves physical function. Community rehabilitation programmes often face limitations in terms of resources. It is imperative to include new motivational interventions to encourage some level of non-clinician management. The aim of this study was to determine whether there were any changes in physical function and activities of daily living when substituting a portion of the standard physiotherapy time with virtual reality games among community-dwelling stroke survivors.

    METHODS: In this controlled trial, the experimental group received 30 minutes of virtual reality balance games in addition to 90 minutes of standard physiotherapy. The control group continued with their two hours of routine standard physiotherapy. Both groups received 12 therapy sessions: two-hour sessions twice per week for six continuous weeks. Changes in physical function, activities of daily living and balance ability were assessed using the Timed Up and Go test, 30-second Sit to Stand test, Timed Ten-Metre Walk test, Six-Minute Walk test and the Barthel Index, and static balance was assessed using a probalance board.

    RESULTS: Twenty-eight participants completed post-intervention assessments. The results showed a significant within-subject effect on the Timed Up and Go test: F (1, 26) = 5.83, p = 0.02; and the 30-second Sit to Stand test; F (1, 26) = 13.50, p = 0.001. The between-subject effect was not significant (p > 0.05) for any of the outcome measurements.

    CONCLUSION: Substituting a portion of the standard physiotherapy time with virtual reality games was equally effective in maintaining physical function outcomes and activities of daily living among community-dwelling stroke survivors.

    TRIAL REGISTRATION: Australia and New Zealand Clinical Trials Register, ACTRN12613000478718.

    Matched MeSH terms: Virtual Reality Exposure Therapy/methods*
  4. Sun X, Ramoo V, Ma J, Yunos NM
    Medicine (Baltimore), 2026 Oct 23;105(43):e51180.
    PMID: 42937747 DOI: 10.1097/MD.0000000000051180
    BACKGROUND: Adult intensive care unit (ICU) patients frequently experience psychological distress, pain, sleep disruption, and motor impairments. Virtual reality (VR) has emerged as a promising nonpharmacological adjunct to improve these outcomes, yet existing evidence remains fragmented and inconsistent. This systematic review and meta-analysis synthesized recent clinical trials to evaluate the effectiveness of VR on mental health, pain, sleep, functional outcomes, and delirium in adult ICU patients.

    METHODS: This review followed Preferred Reporting Items for Systematic Reviews and Meta-Analyses (2020) guidance and was registered in International Prospective Register of Systematic Reviews (CRD42023482529). Eight databases were searched for randomized controlled trials published between January 2000 and September 2025. Eligible studies included adult ICU patients receiving immersive or non-immersive VR interventions. Primary outcomes were anxiety, depression, and post-traumatic stress disorder (PTSD); secondary outcomes included pain, sleep quality, lower-limb function, and bedside balance. Risk of bias was assessed using the Cochrane RoB tool, and certainty of evidence was graded using Grading of Recommendations Assessment, Development and Evaluation.

    RESULTS: Twenty randomized controlled trials were identified, involving a total of 1551 patients. This meta-analysis showed that VR intervention helped improve anxiety (standardized mean difference [SMD] = -0.67, 95% confidence interval [CI: -1.00 to -0.35], P 

    Matched MeSH terms: Virtual Reality Exposure Therapy*
  5. Namazinia M, Mohajer S, Abbaspour S, Lopez V, Sarboozi-Hoseinabadi T
    J Vasc Access, 2025 Mar;26(2):531-539.
    PMID: 38326286 DOI: 10.1177/11297298231225755
    BACKGROUND: Chronic kidney disease (CKD) is characterized by irreversible damage to renal function. For patients undergoing replacement therapies like hemodialysis (HD), the pain caused by arteriovenous fistula (AVF) cannulation becomes a significant aspect of their daily lives. This study aimed to examine the impact of virtual reality (VR) distraction techniques on the pain experienced during AVF needle insertion in patients undergoing HD.

    MATERIALS AND METHODS: This randomized clinical trial (RCT) recruited a total of 60 patients undergoing HD from the 9 Dey Hospital in Torbat Heydariyeh, Iran, between March and August 2022. These patients were then divided into two groups: the intervention group and the control group. The intervention group received distraction techniques using the Shinecon 4th Gen Virtual Reality Headset, while the control group received routine care services. To assess the level of pain experienced during AVF cannulation, the Visual Analog Scale (VAS) was utilized. The collected data were analyzed using SPSS20. Various statistical tests, including the Chi-square test, Mann-Whitney U test, Multiple linear regression, and independent-samples t-test, were employed for data analysis. Additionally, Cohen's d was used to determine the effect size of the intervention.

    RESULTS: The analysis of the data revealed a statistically significant difference in the mean (SD) pain scores between the control group (7.6 ± 0.8) and the intervention group (5.1 ± 0.9) (p virtual reality (VR) was effective in reducing the intensity of pain experienced during AVF needle insertion in patients undergoing HD. Based on these results, it is recommended to incorporate VR as a routine practice in the HD department of the hospital.

    TRIAL REGISTRATION: This study, with the code no. IRCT20180429039463N3, was registered on the Iranian Registry of Clinical Trials on 28/03/2022.

    Matched MeSH terms: Virtual Reality Exposure Therapy
Filters
Contact Us

Please provide feedback to Administrator (afdal@afpm.org.my)

External Links